Company: BOLT
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0000950170-25-069188
Chunk: 1

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
 2024, respectively

     —

     —

     Additional paid-in capital

     485,213

     484,504

     Accumulated other comprehensive gain

     40

     97

     Accumulated deficit

     (438,443
     )

     (427,403
     )

     Total stockholders' equity

     46,810

     57,198

     Total liabilities and stockholders' equity
      
     $
     85,862

     $
     99,632

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.